124 related articles for article (PubMed ID: 20948253)
1. [Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
Morimoto M; Takemura H; Yui T; Suzuki T; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1903-6. PubMed ID: 20948253
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer].
Shimane T; Mori T; Ono T; Kaburagi A; Monden T; Furuya A; Kamakazu K; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Feb; 37(2):241-4. PubMed ID: 20154477
[TBL] [Abstract][Full Text] [Related]
3. [Laryngeal cancer treatment outcomes in our department].
Egawa S; Shimane T; Akiyama R; Ikenoya Y; Uzuki A; Sugimoto A; Hayashi T; Ikeda K; Sanbe T
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1301-5. PubMed ID: 21829068
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of concurrent chemoradiotherapy with S-1 plus nedaplatin for hypopharyngeal cancer].
Kobayashi S; Shimane T; Egawa S; Ono T; Mori T; Kamakazu K; Sanbe T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):233-5. PubMed ID: 21368486
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
[TBL] [Abstract][Full Text] [Related]
6. [A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy].
Akiyama R; Shimane T; Kobayashi S; Ikeda K; Egawa S; Ikenoya Y; Uzuki A; Sugimoto A; Hayashi T; Sanbe T
Gan To Kagaku Ryoho; 2011 Apr; 38(4):631-3. PubMed ID: 21498993
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Ohashi T; Ohnishi M; Tanahashi S; Murai M
Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
[TBL] [Abstract][Full Text] [Related]
8. [Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Takemura H; Kobayashi S; Katsuno M; Asano R; Morimoto M; Tachibana S; Kubota H; Iida M; Kadokura Y; Sanbe T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2065-9. PubMed ID: 16352930
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
10. [Effects of concurrent S-1, nedaplatin/radiation therapy for 5 cases of head and neck cancer with esophageal carcinoma].
Shimane T; Mori T; Ono T; Egawa S; Furuya A; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1349-52. PubMed ID: 20647725
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of simultaneous combination therapy using S-1, nedaplatin and radiotherapy for 7 cases of oropharynx cancer].
Shimane T; Mori T; Ono T; Kaburagi A; Egawa S; Furuya A; Kamakazu K; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1535-7. PubMed ID: 20716881
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
13. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of concurrent chemoradiotherapy with S-1 or CDDP for pharyngeal or laryngeal cancer].
Kuratomi Y; Satoh S; Monji M; Yokogawa K; Suzuki K; Shimazu R; Tokumaru S; Inokuchi A
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1471-6. PubMed ID: 20716870
[TBL] [Abstract][Full Text] [Related]
15. [Laryngeal preservation for hypopharyngeal cancer by radiotherapy with S-1 and vitamin A(TAR therapy)].
Nakashima T; Toh S; Shiratsuchi H; Yasumatsu R; Fukushima J; Nakamura K; Shioyama Y; Komune S
Gan To Kagaku Ryoho; 2012 May; 39(5):759-63. PubMed ID: 22584327
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
Iwase H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
[TBL] [Abstract][Full Text] [Related]
18. [Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
Fan QX; Wang R; Lu P; Zhao YF; Lu TY; Han JW; Wang JS; Luo SX; Lu SP; Wang GJ; Geng L; Zhang MZ; Ma ZY; Song M; Wu XA; Chen XB; Jiao ZM; Wang RL
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):937-9. PubMed ID: 19173998
[TBL] [Abstract][Full Text] [Related]
19. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J
Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
